Ischemic heart disease decisions — 2026

The Board has determined that there were duty to assist errors in the adjudication of the Veteran's claims for service connection for hypertension and heart disability. The claims are being remanded for further development.

The Veteran's TDIU claim was denied because his service-connected disabilities did not meet the schedular requirements for a TDIU, despite meeting the criteria at the time of the February 2024 rating decision.

The Board denied the Veteran's claim for service connection for ischemic heart disease (now claimed as coronary artery disease), finding that there was no evidence of herbicide exposure during service and insufficient medical evidence to establish a link between the current condition and service.

The Board has remanded four issues related to the Veteran's daughter, including a claim for anal fistula, right knee injury residuals, left ear hearing loss, and valvular heart disease. The decision also notes that no fiduciary was appointed on behalf of the Appellant due to her adoption.

The Veteran's claims for service connection for arterioslerotic heart disease, hypertension, diabetes mellitus type II, chloracne, dermatitis, folliculitis, actinic keratosis, and dyshydrosis have been granted.,Service connection is established for the Veteran's arterioslerotic heart disease to include status post coronary artery bypass graft from July 25, 2011. The hypertension, diabetes mellitus type II, and chloracne claims are also granted under presumptive service connection due to herbicide exposure.

The Veteran's service-connected asthma, COPD, and sleep apnea prevented him from securing and following substantially gainful employment before May 27, 2021.

The Veteran's appeal for service connection on multiple conditions has been dismissed due to his death during the pendency of the appeal.

The Veteran's coronary artery disease with congestive heart failure associated with herbicide exposure is rated at 100 percent, the highest disability rating available.

The Board has remanded the Veteran's service connection claims for additional analysis regarding whether obesity served as an intermediate step between his service-connected right knee disability and the development of his secondarily claimed conditions.

The Veteran's claim for an increased rating and SMC based on housebound status for his service-connected coronary artery disease (CAD) prior to March 18, 2025, was denied. The Board found that the evidence did not support a higher disability rating for CAD before this date.

The Veteran's service-connected disabilities, including PTSD, CAD, migraines, tinnitus, bilateral hearing loss, and scars associated with CAD, have rendered him unemployable prior to July 29, 2025. The Board has granted a TDIU for this period.

The Veteran's bladder cancer residuals, hypothyroidism, and arteriosclerotic heart disease have been granted service connection. The Veteran is rated at a 40% for his bladder cancer residuals.

The Veteran's cardiovascular conditions are related to his presumed exposure to contaminants in the water supply while stationed at Camp Le of Lejeune, and service connection is granted.

The Veteran's coronary artery disease with myocardial infarction is granted as service connected due to exposure at Camp Lejeune. The appeals for the other conditions are dismissed as withdrawn.

The Board has granted service connection for basal cell carcinoma with residual scars, chronic kidney disease, and coronary artery disease. The Veteran's conditions are linked to his active duty service.

The Veteran was awarded a temporary total disability rating for coronary artery disease (CAD) from August 5 to September 11, 2002. The appeal is dismissed as moot.

The Board has granted the appellant's request for an earlier effective date of September 26, 2021 for the award of service connection for ischemic heart disease. The lumbar disability claim is remanded due to pre-decisional duty to assist error.

The Veteran's lung disorder, diagnosed as emphysema and restrictive lung disease, is now service-connected. The TDIU claim is being remanded for further development.

The Board has determined that the decision denying eligibility for PCAFC was not legally adequate due to an insufficient medical opinion, and therefore remanded the case.

The Board has granted earlier effective dates of October 23, 2019, for service connection of coronary artery disease with cardiomyopathy (CAD), hypertension (HTN), diabetes mellitus type II (DM II), and left lower extremity neuropathy secondary to DM II.